Revesta
Revesta Cholecalciferol Capsules Rx Only
Approved
Approval ID
e5567a73-bf94-4bad-ade6-ddef18c8af04
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 16, 2019
Manufacturers
FDA
Sterling Knight Pharmaceuticals,LLC
DUNS: 079556942
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Revesta
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code69336-330
Product Classification
G
Generic Name
Revesta
Product Specifications
Route of AdministrationORAL
Effective DateDecember 16, 2019
FDA Product Classification
INGREDIENTS (10)
SOYBEAN OILInactive
Code: 241ATL177A
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
YELLOW WAXInactive
Code: 2ZA36H0S2V
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
LECITHIN, SOYBEANInactive
Code: 1DI56QDM62
Classification: IACT
FOLIC ACIDActive
Quantity: 1 mg in 1 1
Code: 935E97BOY8
Classification: ACTIB
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
CHOLECALCIFEROLActive
Quantity: 5750 [iU] in 1 1
Code: 1C6V77QF41
Classification: ACTIB